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In cardiac and peripheral arterial surgery, there is
a need for small caliber grafts for arterial reconstruc-
tion. Although in coronary artery bypass grafting
the internal mammary artery is considered the graft
of choice, the widespread use of the saphenous vein
continues because of the limitations in the use of the
internal mammary artery, because of the lack of suf-
ficient arterial conduit for grafting in patients with
multiple-vessel disease.1,2 However, saphenous veins
under arterial pressure experience an accelerated ath-
erosclerotic process.3 For this reason, different types
of grafts, either natural or synthetic, are being inves-
tigated as substitutes for saphenous vein and as a
complement of the internal mammary artery.
The preservation of functional endothelium is
essential to maintain the vascular tone and antithrom-
botic properties of a vessel. Therefore an adequate
preservation of the arterial wall function may play a
role in medium and long-term patency of small caliber
arterial grafts. 
Cryopreservation is a well-developed technique
to preserve both valvular grafts4 and large-caliber
arterial allografts.5 The clinical need for arterial
grafts in coronary surgery has increased the interest
in this technique of banking small-caliber arterial
grafts. Cryopreservation of small arterial vessels has
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already been shown to be a useful technique for the
storage of animal and human arteries. Nevertheless,
most cryopreservation studies have used other
methods and short arterial segments, which are only
suitable for pharmacologic testing but not for graft-
ing purposes.6 The relaxant and contractile respons-
es of cryopreserved arteries in these studies vary con-
siderably, mainly because of the differences in the
susceptibility to cryoinjury of the endothelial and
smooth muscle cells from different arteries and to
the cryopreservation procedures used.7-12
The aim of the present study was (1) to design a
computerized program to cryopreserve pig femoral
arteries, (2) to assess whether different storage times
may affect the endothelial function of these cryopre-
served arteries, and (3) to study the antithrombotic
and ultrastructural endothelium properties of cryo-
preserved banked arteries.
METHODS
Thirty-six common pigs, a mixture of Landrace
and Largewhite breeds, were used in this study. They
were purchased from a local farmer and were fed a
regular diet. They were 4 months old, a mixture of
male and female with a mean body weight of 29 ± 5
kg. All procedures were performed according to the
Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health
(NIH Publication No 85-23, revised 1996) and the
guidelines of the local government.13
The animals were sedated with an intramuscular
injection of azaperone (2 mg/kg) and were anes-
thetized with thiopental 30 mg/kg; thereafter, anes-
thesia was maintained with intravenous thiopental
(0,2 mg/kg/min). They were intubated and con-
nected to a volumetric ventilator with a mixture of
oxygen and air room. The carotid artery was dis-
sected and catheterized with 8F sheaths (Input 8F;
BARD, CR Bard Ireland Ltd, Galway, Ireland) to
withdraw blood for perfusion studies.
Blood samples were mixed with citrate-phos-
phate-dextrose as anticoagulant, with a final concen-
tration of 13 mmol/L. After both femoral arteries
were harvested, the animals were killed with a large
dose of intravenous thiopental. 
Tissue preparation and storage methods. The
femoral arteries were dissected, carefully removed,
and divided into seven groups. Group A (n = 10
arteries) consisted of fresh vessels, which were used
immediately after removal for organ bath, perfusion
studies, and electronic microscopy and served as a
control group. 
In groups B1 (n = 9 arteries) and B2 (n = 10
arteries), the femoral arteries were cut into smaller
segments of about 1.5 cm and placed in 2 mL liquid
nitrogen storage ampoules (Cryotubes Nunc; Lab
Clinics, Barcelona, Spain) filled with RPMI 1640 tis-
sue culture media (BioWhittaker, Walkersville, Md)
containing 10% fetal calf serum (FCS) and 10% of
dimethylsulfoxide (DMSO). The ampoules were
then introduced in a programmable freezer (Cryoson
BV-10; Carburos Metálicos SA, Barcelona, Spain)
and slowly frozen at a cooling rate of 1˚C per minute
(group B1) or 0.3˚C per minute (group B2). After
the cryopreservation process, the ampoules were
transferred to liquid nitrogen (–196˚C) and stored
for 90 days.
Because contractile response of arteries that were
cryopreserved with this technique was abolished, the
following modifications were introduced in the cryo-
preservation technique for groups C1 to C4. The
arterial segments (approximately 4 cm) were placed in
plastic bags (Cryocyte Freezing container, Pl 269
plastic; Baxter Healthcare Corporation, Irvine, Calif)
filled with 100 mL of modified Krebs-Henseleit
(NaCl 118 mmol/L, glucose 11 mmol/L, NaHCO3
25 mmol/L, KCl 4.7 mmol/L, MgSO4 1.2
mmol/L, KH2PO4 1.2 mmol/L, CaCl2 1.2
mmol/L, EDTA 0.03 mmol/L) solution containing
12% DMSO and 0.1 mol/L sucrose.14 The bags were
then introduced in the same programmable freezer
and slowly frozen at a cooling rate of 0.7˚C per
minute. When –75˚C was achieved, the bags were
transferred to liquid nitrogen (–196˚C) and stored for
1 day (group C1; n = 6 arteries), 15 days (group C2;
n = 7 arteries), 60 days (group C3; n = 7 arteries), or
180 days (group C4; n = 3 arteries). Table I shows the
different techniques of programmed cryopreservation
and the study length for each study group.
At removal from the liquid nitrogen, the femoral
arteries were thawed by placing the ampoules and
bags in a 37˚C water bath for approximately 3 min-
utes. Thereafter, the vessels were rinsed in a dish con-
taining Krebs-Henseleit solution. The femoral arter-
ies were then examined immediately for their con-
traction and endothelial-dependent vasodilation in
the organ bath. Perfusion and electronic microscopy
studies were also performed only in groups A and C
to assess the antithrombotic properties and the struc-
ture of the endothelial layer, respectively. 
Organ bath. One section of each artery was
cleaned of adherent connective tissue and cut into
rings of approximately 5 mm in length. Special care
was taken to avoid contact with the luminal surface
of the blood vessel to preserve the endothelial layer.
The rings were mounted horizontally between two
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stainless steel stirrups in individual organ bath cham-
bers filled with 10 mL of Krebs-Henseleit solution.
The saline solution was constantly bubbled with a
mixture of 95% oxygen-5% carbon dioxide and main-
tained at 37˚C with an outer jacket and circulating
heat pump. Changes in tension were measured with
an isometric transducer (TRI 201; Leica SA,
L’Hospitalet, Spain) and recorded in a multichannel
polygraph Uni-Graph 2000-506 (Leica SA). The
rings were allowed to equilibrate for 120 minutes
with several adjustments until a baseline force of 12
g was obtained. In previous experiments, we found
that a resting tension of 12 g is optimal for the
expression of 10–7 mol/L norepinephrine-induced
contraction of femoral rings obtained from control
pigs. All the experiments were performed in the pres-
ence of 10–5 mol/L indomethacin to prevent the
release of endogenous prostanoids.
After the equilibration period, the rings were
contracted with 10–7 mol/L norepinephrine. This
dose induced approximately 40% (6320 ± 1225 mg)
of maximal contraction (16240 ± 2456 mg) in the
contraction-response curves of previous experiments
from this laboratory (Fig 1; unpublished results).
When the contractile response had reached a
plateau, the preparations were exposed to cumula-
tive concentrations (10–9 to 10–4 mol/L) of acetyl-
choline. The relaxant activity of the agonist was
expressed as a percentage of reduction of the tension
developed by norepinephrine. 
Perfusion studies. The endothelial antithrom-
botic properties were evaluated under blood flow
conditions. Perfusions were performed at 37˚C in
perfusion chambers as developed by Baumgartner15
with an effective annular width of 2.2 mm and a rod
length of 7.2 cm. Blood flow was obtained by
pumping blood through a peristaltic pump. Pig
blood was perfused at 140 mL/min (wall shear rate
800/sec). One section of each artery was everted,
mounted on a plastic rod, and rinsed with phosphate
buffered saline solution (PBS; BioMérieux, Marcy,
l’étoile, France) for 10 minutes. After 10 minutes of
perfusion with the blood samples, the segments
were rinsed with the same phosphate buffer and
fixed with 3% glutaraldehyde.
After 1 hour, the segments were separated from
the rods, washed with PBS, dehydrated through a
graded series of ethanol, embedded in JB-4 embed-
ding material (Polysciences, Warrington, Pa), thin
cross-sectioned for light microscopy (3 µm), and
stained with toluidine blue. Platelet interactions with
the arterial wall were morphometrically evaluated
with the use of a computerized image analysis sys-
tem.16 The morphometric parameters were deter-
mined according to the criteria previously established
by Baumgartner.17 Briefly, platelets or groups of
platelets were classified as (1) contact (platelets that
were attached to but not spread on the endotheli-
um); (2) adhesion (platelets that had spread on the
endothelial surface, including small aggregates of less
than 5 µm in height); and (3) thrombi (platelet
aggregates of more than 5 µm in height). All these
basic parameters were expressed as a percentage of
the total surface examined. Another parameter relat-
ed to those previously defined was the total covered
surface, which was determined by adding contact +
adhesion + thrombi. 
Electron microscopy. One section of each
artery was placed in 2.5% glutaraldehyde for scan-
ning electron microscopy. The section was postfixed
in 1% osmium tetraoxide in PBS, dehydrated in
graded ethanols, critical point-dried, and stored in a
dessicator. The sections were then gold coated
(Polaron E500; Polaron Watford Hertfordshire,
England) and viewed with a Leica LC-360 scanning
electron microscope (Leica, Cambridge, England)
to assess the integrity of the endothelial layer.
Drugs. All drugs (azaperone 2 mg/kg, intra-
muscularly [Stresnil; Esteve, Barcelona, Spain]; sodi-
um thiopental is 30 mg/kg, intravenous bolus, to
induce anesthesia and intravenous perfusion 0.25
mg/kg/min [Pentotal; Laboratorio Abbot, Madrid,
Spain]; indomethacine 10–5 mol/L [Sigma Quimica,
Alcobendas, Madrid, Spain]; norepinephrine 10–7
Table I. Different techniques and storage times of programmed cryopreservation for each study group
Group B Group C
Group B1 Group B2 Group C1 Group C2 Group C3 Group C4
Arteries (n) 9 10 6 7 7 3
Cryomedium RPMI 1640, 10% DMSO, 10% FCS Modified Krebs-Henseleit, 12% DMSO, 0.1 mol/L sucrose
Cooling rate (˚C/min) 1 0.3 0.7 0.7 0.7 0.7
Storage at 90 90 1 15 60 180
–196˚C (day)
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mol/L [Sigma Quimica]; acetylcholine 10–9 to 10–4
mol/L [Sigma Quimica]; and sucrose 0.1 mol/L
[Sigma Quimica]) were freshly prepared daily in dis-
tilled water (except for norepinephrine, which was
dissolved in HCl 1%). All drugs were properly diluted
and added to the organ bath in volumes of 100 µL.
Concentrations are expressed as final molar concen-
tration in the organ chambers.
Statistical analysis. All values are expressed as
mean ± SD of the mean. A one-way analysis of vari-
ance was used to compare means between different
groups. Significant levels were adjusted for multiple
comparisons by the Scheffe method. A probability
value of less than .05 indicated a significant differ-
ence. The statistical calculations were performed with
the SPSS/PC package (SPSS, Inc, Chicago, Ill).
RESULTS
Contractile responses. Table II shows the con-
tractile responses of femoral arteries induced by 10–7
mol/L norepinephrine for groups A and C. The
vasoconstrictor response to the norepinephrine in the
control arteries (group A) was 13010 ± 3181 mg; in
groups B1 and B2, it was zero. However, in groups
C1 to C4, the contractile responses to the norepi-
nephrine were approximately 50% with respect to the
fresh arteries (group A; P < .01). There were no sig-
nificant differences between storage times.
Relaxant responses. Fig 2 illustrates the effect
induced by an increase in the concentrations of
acetylcholine in fresh and cryopreserved arteries.
Table II also shows the maximal endothelium-
dependent relaxation, expressed as a percentage of
the induced contraction. Endothelium-dependent
relaxation could not be investigated in groups B1
and B2 because they had lost contractility. No sig-
nificant changes in the response to acetylcholine
were observed between fresh (group A) and cryo-
preserved arteries (groups C1 to C4); it was inde-
pendent of the storage time. 
Perfusion studies. Platelet interaction with the
endothelium was almost absent in control arteries
(group A) and in all cryopreserved arteries studied
(groups C1 to C4). Moreover, there were no differ-
ences between different storage times. Fig 3 shows
perfusion studies of fresh and cryopreserved arteries
of groups C3 and C4.
Electron microscopic examination. All cryo-
preserved arteries (groups C1 to C4) exhibited con-
fluent endothelial surfaces. No morphologic differ-
ences could be made between fresh (group A) and
cryopreserved arteries. There were no differences
between different storage times. Representative scan-
ning electron microscopic images of arterial endothe-
lium from groups A and C2 are shown in Fig 4.
DISCUSSION
The results of this study demonstrate that
endothelial morphologic features and function are
maintained in porcine femoral arteries, when cryo-
preserved with a technique consisting of a cooling
rate of 0.7˚C per minute and a modified Krebs-
Fig 2. Relaxations in response to increasing concentra-
tions of acetylcholine in fresh and cryopreserved arteries
stored for 1, 15, 60, and 180 days. Values are expressed as
percentage of the induced contraction by 10–7 mol/L
norepinephrine.
Fig 1. Dose-response curve to norepinephrine in rings
preparation of femoral arteries (n = 3 arteries; 12 rings).
Values are expressed in milligrams.
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Henseleit solution that contains 12% of DMSO and
0.1 mol/L sucrose as cryomedium. In contrast, the
arteries cryopreserved with the standard technique
for cardiac valve cryopreservation lost both smooth
muscle and endothelial cells function. We have also
shown that this preservation is not negatively affect-
ed by the storage in liquid nitrogen up to 6 months.
During the cryopreservation process, the cryo-
medium and the cooling rate are determinants of the
cell damage by the formation of intracellular and
extracellular ice crystals and by the osmotic disequi-
librium because of concentrated electrolytes during
freezing.9 Therefore an adequate cryopreservation
procedure is essential for the postthawed recovery of
vascular function. 
In this study, we used modified Krebs-Henseleit
solution containing 12% of DMSO and 0.1 mol/L
sucrose, without amino acids and vitamins, and a
cooling rate of 0.7˚C per minute as an effective
method to preserve pig femoral arteries. The
increase in the viability of the arteries could be
ascribed to both, the cryopreservation solution and
the freezing rate. However, we think that, because
both solutions used in this study have been used suc-
cessfully by other authors, the major changes in the
freezing rate may be the most important factor in
the differences found in our study. Therefore arter-
ies cryopreserved in such a way showed an approxi-
mate 50% reduction in the contractility when
exposed to norepinephrine, as compared with fresh
Table II. Maximal contractile and relaxant responses to norepinephrine and acetylcholine, respectively, of
fresh (group A) and cryopreserved arteries (groups C1 to C4)
Group A
Group C
Group C1 Group C2 Group C3 Group C4
Arteries (n) 10 6 7 7 3
Contraction to 
norepinephrine (mg) 13010 ± 3181 5354 ± 1222* 5187 ± 2672* 6867 ± 2292* 7000 ± 2858*
Vasodilation (%) to
acetylcholine 99 ± 3 90 ± 13 92 ± 12 89 ± 15 88 ± 22
All values are expressed as mean ± SD. 
*P < .001, vs group A, by one-way analysis of variance.
Fig 3. Light micrographs obtained from cross-sections of everted segments of fresh (A) and
cryopreserved arteries stored for 60 (B) and 180 days (C). The arrows show endothelial cells.
In all cases, the interaction of platelets with the endothelium is almost absent. (Toluidine blue
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studied arteries. These results compare favorably
with those observed in other vascular segments, such
as human coronary arteries, in which contraction
responses have been reported to be only 20% to 30%
that of fresh ones.10
Our results are similar to the findings of Müller-
Schweinitzer et al14,18 in canine femoral, human
mesenteric, and left circumflex coronary arteries.
These authors observed contractile responses similar
to those of the present investigation. However, in
the present investigation, the maximal endothelial-
dependent relaxation was similar between cryopre-
served and fresh arteries (approximately 90% of the
induced contraction) and higher than the 30% to
50% reported by Müller-Schweinitzer et al. The two
main reasons for these differences can be ascribed to
a variation in susceptibility to the cryopreservation
procedure, which may vary from tissue to tis-
sue,6,10,18,19 and to methodologic differences in the
cooling process. We used a computerized program
that was designed and is used in our institution to
ensure a constant slow rate of 0.7˚C per minute, in
contrast to the manual cooling rate. Moreover, the
greater detrimental effect of the cryopreservation on
contraction as compared with vasodilation may be
related to the density and packing of the smooth
muscle cells in large arteries, which supports the idea
that different cell types have a different susceptibili-
ty to the freezing procedure.9,20
Pompilio et al21 demonstrated a full preservation
of the relaxant activity and vasoconstrictor response
in human mammary arteries after cryopreservation
using RPMI, FCS, and DMSO as cryomedium and
a computerized cooling rate of 1˚C per minute.
However, these results have not been reproduced by
any other author. In fact, with the methods of
Pompilio et al, Nataf et al12 and Vischjager et al22
found (as we did in our groups that were preserved
by the standard technique) a severe damage of the
vascular segments with extremely poor contraction
in human mammary arteries and canine carotid
arteries, respectively.
It has been previously demonstrated that storage
at –196˚C yields a better preservation of vascular
function than storage at –70˚C.23 However, it is not
well known whether continued storage of small cal-
iber arteries at –196˚C could affect arterial function. 
The present investigation has addressed this
question and has demonstrated that storage for an
extended period of time in liquid nitrogen at
–196˚C does not negatively affect the vascular func-
tion. Our results are different from those of Ku et al8
who reported that cryopreserved canine coronary
arteries stored for 1 day at –75˚C showed contractile
and relaxant responses not significantly different
from the fresh control, although longer cryostorage
at –75˚C resulted in a significant decrease in these
responses. This difference can be probably related to
the different banking temperature. In that sense,
Brockbank et al24 found that the contractile respons-
es generated by long-term storing (more than 2
years at less than –150˚C) of cryopreserved canine
saphenous veins were the same as in the short-term
storage of veins (1-28 days at less than –150˚C).
These authors demonstrated that vein viability is
maintained in cryopreserved banked veins, as we
have done with pig femoral arteries.
Our study also investigated the antithrombotic
properties and endothelial morphologic features of the
cryopreserved arteries. These two aspects have never
been looked at previously in studies with the present
cryopreservation methods. The fact that a cryopre-
served artery retains its antithrombotic properties (no
platelet adhesion) is a very relevant finding to predict
Fig 4. Scanning electron micrographs of fresh (A) and
cryopreserved arteries stored for 15 days (B). In both
cases, the endothelium is confluent, and the cell morpho-
logic condition is normal. (Original magnification, ×200.)
A
B
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the future patency when used as a grafting segment. In
this sense, the preservation of the endothelial layer
morphologic features further confirms that this
method fully respects the vascular structure.
Clinical relevance. In spite of antiplatelet treat-
ment, saphenous venous grafts still have a high attri-
tion rate, as compared with arterial conduits.
Furthermore, the number of patients who require a
second intervention is increasing as the population
ages. Therefore cryopreserved arteries may represent a
useful alternative to saphenous vein. We can speculate
that preservation of vascular function, including the
endothelial antithrombotic properties, may help to
preserve the graft patency. In this sense, the cryop-
reservation technique developed in the present investi-
gation may offer better vascular grafts for cardiovascu-
lar surgery and peripheral vascular surgery. However,
the performance of cryopreserved grafts when
implanted in the circulation and the effect of rejection
should be addressed in further studies. At this
moment, our group has started to implant cryopre-
served femoral arteries in a porcine model, and histo-
logic analysis to observe tissue viability and immuno-
logic rejection is underway. Other authors25-27 have
already published studies that deal with cryopreserved
allografts used for arterial bypass grafting. In that
sense, Pacholewicz et al25 cryopreserved internal
mammary canine arteries and obtained overall patency
rates of 75% at 90 days when they were used as graft-
ing segments, which suggests that these cryopreserved
arteries may have potential as a substitute graft.
In conclusion, the results from the present study
indicate that computerized cryopreservation, with a
cooling rate of 0.7˚C per minute and modified
Krebs-Henseleit solution that contains 12% DMSO
and 0.1 mol/L sucrose as cryomedium, preserves
the morphologic condition and function of porcine
femoral arteries. These findings are not negatively
affected by the storage time in liquid nitrogen,
which supports the feasibility of small caliber arteri-
al banking. Moreover, the preservation of the
antithrombotic and ultrastructural endothelial prop-
erties of cryopreserved banked arteries may ensure
their patency when they are used as arterial grafts.
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